{
    "clinical_study": {
        "@rank": "11432", 
        "arm_group": [
            {
                "arm_group_label": "dexamethasone", 
                "description": "Patients who receive dexamethasone (8 mg; Decadron; Merck Sharp & Dohme) intravenously 90 min before skin incision"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "Patients who receive saline placebo intravenously 90 min before skin incision"
            }
        ], 
        "brief_summary": {
            "textblock": "Recurrent laryngeal nerve dysfunction and hypoparathyroidism are well-recognized important\n      complications of thyroid surgery. The duration of convalescence, after non complicated\n      thyroid operation, may depend on several factors of which pain and fatigue are the most\n      important. Nausea and vomiting occur mainly on the day of operation. Glucocorticoids are\n      well known for their analgesic, anti-inflammatory, immune modulating and antiemetic effects.\n      The investigators therefore undertook the present study to investigate whether preoperative\n      dexamethasone could improve surgical outcome in patients undergoing thyroid surgery."
        }, 
        "brief_title": "Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy", 
        "completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Benign Neoplasm of Thyroid Gland", 
            "Malignant Neoplasm of Thyroid"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Thyroid Neoplasms", 
                "Thyroid Diseases", 
                "Brain Neoplasms", 
                "Vocal Cord Paralysis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing thyroid surgery\n\n        Exclusion Criteria:\n\n          -  ASA physical class III or IV\n\n          -  age > 75 years\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patients undergoing thyroid surgery for benign and malignant thyroidal disease"
            }
        }, 
        "enrollment": {
            "#text": "328", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01690806", 
            "org_study_id": "OTO: OTO12-0447R"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 25, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "L'Aquila", 
                    "country": "Italy", 
                    "state": "AQ", 
                    "zip": "67100"
                }, 
                "name": "ospedale San Salvatore-Reparto di Chirurgia Generale Universitaria"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "2", 
        "official_title": "Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy (and Not Only) After Thyroid Surgery. A Randomized Double-blind Placebo-controlled Trial.", 
        "overall_official": {
            "affiliation": "Universit\u00e0 degli Studi dell'Aquila", 
            "last_name": "Emanuela M CECILIA, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01690806"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e0 degli Studi dell'Aquila", 
            "investigator_full_name": "CECILIA Emanuela Marina", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Universit\u00e0 degli Studi dell'Aquila", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e0 degli Studi dell'Aquila", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2011"
    }
}